홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Citric Acid → 5-bromo-N-(5-fluorothiazol-2-yl)-3,4-dihydroisoquinoline-2(1H)-sulfonamide

HRID 2172286
인쇄

반응식

HRID 2172286 반응식
Cl.[F:2][C:3]1[S:7][C:6]([NH2:8])=[N:5][CH:4]=1.N1C=CN=C1.[S:14](Cl)(Cl)(=[O:16])=[O:15].Cl.[Br:20][C:21]1[CH:30]=[CH:29][CH:28]=[C:27]2[C:22]=1[CH2:23][CH2:24][NH:25][CH2:26]2.CCN(C(C)C)C(C)C.C(O)(=O)CC(CC(O)=O)(C(O)=O)O>C(Cl)Cl.C1COCC1.CCCCCCC>[Br:20][C:21]1[CH:30]=[CH:29][CH:28]=[C:27]2[C:22]=1[CH2:23][CH2:24][N:25]([S:14]([NH:8][C:6]1[S:7][C:3]([F:2])=[CH:4][N:5]=1)(=[O:16])=[O:15])[CH2:26]2
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 6

HCID 311Citric AcidHCID 795ImidazoleHCID 24648Sulfuryl chlorideHCID 81531DiisopropylethylamineHCID 118589315-Fluoro-1,3-thiazol-2-amine hydrochlorideHCID 450740035-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride

생성물 1

HCID 89815577
5-bromo-N-(5-fluorothiazol-2-yl)-3,4-dihydroisoquinoline-2(1H)-sulfonamide
수율 41.2%

시약·촉매·용매 3

HCID 6344Dichloromethane용매HCID 8028Tetrahydrofuran용매HCID 8900Heptane용매

실험 절차

A solution of 5-fluorothiazol-2-amine hydrochloride (Milestone Pharmatech, Brunswick, N.J., 6.22 g, 40.2 mmol) and 1H-imidazole (10.96 g, 161 mmol) in 200 mL DCM was cooled to −78° C. and was treated with sulfuryl chloride (3.27 ml, 40.2 mmol). After stirring for 10 minutes, the reaction mixture was placed into a 0° C. bath and was allowed to stir for an additional hour. To this mixture was added 30 mL of heptane and the solvent was decanted. The remaining solid was treated with 5-bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride (ASW Medchem, Brunswick, N.J., 5.00 g, 20.12 mmol) then treated sequentially with 100 mL THF and DIPEA (42.2 ml, 241 mmol). The reaction mixture was heated to reflux for one hour before being cooled and poured into 1N citric acid. The desired product was extracted with ethyl acetate. The organics were concentrated and the resulting residue was purified directly by silica gel column chromatography (0 to 100% EtOAc/heptane, 2% MeOH) yielding 5-bromo-N-(5-fluorothiazol-2-yl)-3,4-dihydroisoquinoline-2(1H)-sulfonamide (3.25 g, 8.29 mmol). [M+H]+=393.9

후처리

  1. customwas placed into a 0° C.
  2. stirringto stir for an additional hour
  3. customthe solvent was decanted
  4. temperatureThe reaction mixture was heated
  5. temperatureto reflux for one hour
  6. temperaturebefore being cooled
  7. extractionThe desired product was extracted with ethyl acetate
  8. concentrationThe organics were concentrated
  9. customthe resulting residue was purified directly by silica gel column chromatography (0 to 100% EtOAc/heptane, 2% MeOH)

출처 및 근거

ORD 기록
ord-121fb25062784ed5a64c93d0ef08bc54
출처 데이터셋
uspto-grants-2015_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09051311B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트